Next-Generation Antibody Market

1
Next-Generation Antibody Market 
Next-Generation Antibody Market Forecast to 2028
- COVID-19 Impact and Global Analysis By
Therapeutic Area (Oncology and Autoimmune or
Inflammatory) and Technology (Antibody-Drug
Conjugates, Bispecific Antibodies, Fc Engineered
Antibodies, Antibody Fragments and Antibody-Like
Proteins, and Biosimilar Antibody Products)
2
Current and future Market Scenario
Next-Generation Antibody Market 

• According to our new market research study on
  Next-Generation Antibody Market to 2028 Global
  Analysis and Forecast by Therapeutic Area and
  Technology, the market is expected to reach US
  12,050.13 million by 2028 from US 5,468.41
  million in 2021.

3
Market Segments
Next-Generation Antibody Market   
By Therapeutic Area Oncology and
Autoimmune Inflammatory
By Technology Antibody-Drug Conjugates Bispecifi
c Antibodies Fc Engineered Antibodies Antibody
Fragments and Antibody-Like Proteins Biosimilar
Antibody Products
4
Leading Players
Next-Generation Antibody Market  
Company Profiles in Next-Generation Antibody
Market are F. HOFFMANN-LA ROCHE LTD.
Kyowa Kirin Co., Ltd. Seagen Inc.
ImmunoGen, Inc. Takeda
Pharmaceutical Company Limited
Amgen Inc. Pfizer Inc.
Catalent Inc AstraZeneca
Xencor
5
Next-Generation Antibody Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/next-ge
neration-antibody-market
Thank You!

• Thank You!